Literature DB >> 28117940

Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.

J M Diamond1, E Cantu2, M K Porteous1, Y Suzuki2, K C Meyer3, D J Lederer4, R K Milewski2, S Arcasoy4, F D'Ovidio5, M Bacchetta5, J R Sonett5, G Singh5, J Costa5, J W Tobias6, H Rodriguez6, V M Van Deerlin7, K M Olthoff8, A Shaked8, B-L Chang8,9, J D Christie1.   

Abstract

Recipient responses to primary graft dysfunction (PGD) after lung transplantation may have important implications to the fate of the allograft. We therefore evaluated longitudinal differences in peripheral blood gene expression in subjects with PGD. RNA expression was measured throughout the first transplant year in 106 subjects enrolled in the Clinical Trials in Organ Transplantation-03 study using a panel of 100 hypothesis-driven genes. PGD was defined as grade 3 in the first 72 posttransplant hours. Eighteen genes were differentially expressed over the first year based on PGD development, with significant representation from innate and adaptive immunity genes, with most differences identified very early after transplant. Sixteen genes were overexpressed in the blood of patients with PGD compared to those without PGD within 7 days of allograft reperfusion, with most transcripts encoding innate immune/inflammasome-related proteins, including genes previously associated with PGD. Thirteen genes were underexpressed in patients with PGD compared to those without PGD within 7 days of transplant, highlighted by T cell and adaptive immune regulation genes. Differences in gene expression present within 2 h of reperfusion and persist for days after transplant. Future investigation will focus on the long-term implications of these gene expression differences on the outcome of the allograft.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  genomics; lung failure/injury; lung transplantation/pulmonology; molecular biology: mRNA/mRNA expression; translational research/science

Mesh:

Substances:

Year:  2017        PMID: 28117940      PMCID: PMC5489369          DOI: 10.1111/ajt.14209

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  28 in total

1.  Determining significant fold differences in gene expression analysis.

Authors:  A J Butte; J Ye; H U Häring; M Stumvoll; M F White; I S Kohane
Journal:  Pac Symp Biocomput       Date:  2001

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

3.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.

Authors:  G K Geiss; R E Bumgarner; M C An; M B Agy; A B van 't Wout; E Hammersmark; V S Carter; D Upchurch; J I Mullins; M G Katze
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

4.  T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.

Authors:  V Tiriveedhi; M Takenaka; S Ramachandran; A E Gelman; V Subramanian; G A Patterson; T Mohanakumar
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

5.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

6.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

7.  Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

8.  Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.

Authors:  E Cantu; D J Lederer; K Meyer; K Milewski; Y Suzuki; R J Shah; J M Diamond; N J Meyer; J W Tobias; D A Baldwin; V M Van Deerlin; K M Olthoff; A Shaked; J D Christie
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

9.  Early expression profile of inflammatory markers and kidney allograft status.

Authors:  D O McDaniel; D A Rigney; K Y McDaniel; W J Windham; P Redmond; B Williams; X Zhou; A Hawxby; F Butt
Journal:  Transplant Proc       Date:  2013-05       Impact factor: 1.066

10.  Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.

Authors:  E Cantu; Y Suzuki; J M Diamond; J Ellis; J Tiwari; B Beduhn; J R Nellen; R Shah; N J Meyer; D J Lederer; S M Kawut; S M Palmer; L D Snyder; M G Hartwig; V N Lama; S Bhorade; M Crespo; E Demissie; K Wille; J Orens; P D Shah; A Weinacker; D Weill; D Wilkes; D Roe; L B Ware; F Wang; R Feng; J D Christie
Journal:  Am J Transplant       Date:  2015-12-10       Impact factor: 8.086

View more
  4 in total

1.  Preprocurement In Situ Donor Lung Tissue Gene Expression Classifies Primary Graft Dysfunction Risk.

Authors:  Edward Cantu; Mengying Yan; Yoshikazu Suzuki; Taylor Buckley; Vito Galati; Neha Majeti; Christian A Bermudez; Joshua M Diamond; Jason D Christie; Rui Feng
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

Review 2.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

3.  National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.

Authors:  Michael S Mulligan; David Weill; R Duane Davis; Jason D Christie; Farhood Farjah; Jonathan P Singer; Matthew Hartwig; Pablo G Sanchez; Daniel Kreisel; Lorraine B Ware; Christian Bermudez; Ramsey R Hachem; Michael J Weyant; Cynthia Gries; Jeremiah W Awori Hayanga; Bartley P Griffith; Laurie D Snyder; Jonah Odim; J Matthew Craig; Neil R Aggarwal; Lora A Reineck
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08-18       Impact factor: 5.209

4.  Volatile organic compound profiling to explore primary graft dysfunction after lung transplantation.

Authors:  Pierre-Hugues Stefanuto; Rosalba Romano; Christiaan A Rees; Mavra Nasir; Louit Thakuria; Andre Simon; Anna K Reed; Nandor Marczin; Jane E Hill
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.